D.E. Shaw & Co’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $202K | Buy |
|
|||||
|
2022
Q1 | $324K | Buy |
|
|||||
|
2021
Q4 | $305K | Buy |
|
|||||
|
2021
Q3 | $189K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $242K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $548K | Buy |
|
|||||
|
2020
Q1 | $372K | Sell |
|
|||||
|
2019
Q4 | $1.13M | Sell |
|
|||||
|
2019
Q3 | $334K | Sell |
|
|||||
|
2019
Q2 | $298K | Hold |
|
|||||
|
2019
Q1 | $341K | Sell |
|
|||||
|
2018
Q4 | $658K | Sell |
|
|||||
|
2018
Q3 | $900K | Buy |
|
|||||
|
2018
Q2 | $76K | Buy |
|
|||||
|
2018
Q1 | $291K | Buy |
|
|||||
|
2017
Q4 | $218K | Buy |
|
|||||
|
2017
Q3 | $157K | Buy |
|